HomeComparePTRVF vs MRK

PTRVF vs MRK: Dividend Comparison 2026

PTRVF yields 83333.33% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTRVF wins by $7.827354174349132e+25M in total portfolio value
10 years
PTRVF
PTRVF
● Live price
83333.33%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.827354174349132e+25M
Annual income
$78,089,205,798,879,010,000,000,000,000,000.00
Full PTRVF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — PTRVF vs MRK

📍 PTRVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTRVFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTRVF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTRVF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTRVF
Annual income on $10K today (after 15% tax)
$7,083,333.33/yr
After 10yr DRIP, annual income (after tax)
$66,375,824,929,047,160,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, PTRVF beats the other by $66,375,824,929,047,160,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTRVF + MRK for your $10,000?

PTRVF: 50%MRK: 50%
100% MRK50/50100% PTRVF
Portfolio after 10yr
$3.913677087174566e+25M
Annual income
$39,044,602,899,439,506,000,000,000,000,000.00/yr
Blended yield
99.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PTRVF
No analyst data
Altman Z
-10.5
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTRVF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTRVFMRK
Forward yield83333.33%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$7.827354174349132e+25M$57.7K
Annual income after 10y$78,089,205,798,879,010,000,000,000,000,000.00$10,113.78
Total dividends collected$7.826145752529585e+25M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PTRVF vs MRK ($10,000, DRIP)

YearPTRVF PortfolioPTRVF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$8,344,033$8,333,333.33$11,213$373.04+$8.33MPTRVF
2$6,507,396,444$6,498,468,328.14$12,667$512.06+$6507.38MPTRVF
3$4,743,472,976,069$4,736,510,061,874.32$14,439$708.14+$4743472.96MPTRVF
4$3,231,814,615,629,740$3,226,739,099,545,346.00$16,640$988.16+$3231814615.61MPTRVF
5$2,058,071,288,713,008,000$2,054,613,247,074,284,500.00$19,432$1,394.07+$2058071288712.99MPTRVF
6$1,225,015,790,649,354,000,000$1,222,813,654,370,431,000,000.00$23,057$1,992.90+$1225015790649354.00MPTRVF
7$681,543,888,689,022,700,000,000$680,233,121,793,028,000,000,000.00$27,889$2,894.79+$681543888689022720.00MPTRVF
8$354,421,985,930,988,300,000,000,000$353,692,733,970,091,100,000,000,000.00$34,518$4,286.29+$354421985930988290048.00MPTRVF
9$172,276,583,749,827,040,000,000,000,000$171,897,352,224,880,900,000,000,000,000.00$43,912$6,494.35+$1.7227658374982704e+23MPTRVF
10$78,273,541,743,491,320,000,000,000,000,000$78,089,205,798,879,010,000,000,000,000,000.00$57,714$10,113.78+$7.827354174349132e+25MPTRVF

PTRVF vs MRK: Complete Analysis 2026

PTRVFStock

Avila Energy Corporation, an integrated energy company, engages in the development, exploration, and production of oil and natural gas in Canada. It holds a 50% non-operating interest in an oil and gas producing property that covers an area of approximately 7,680 acres located in the West Central Alberta. The company was formerly known as Petro Viking Energy Inc. and changed its name to Avila Energy Corporation in December 2021. Avila Energy Corporation is based in Calgary, Canada.

Full PTRVF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PTRVF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTRVF vs SCHDPTRVF vs JEPIPTRVF vs OPTRVF vs KOPTRVF vs MAINPTRVF vs JNJPTRVF vs ABBVPTRVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.